| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Iroquois Nursing Home is a Jamesville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Uams/Ecco Head Start Program is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fulton Co. Emergency Medical Association, Inc. is a Canton, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InSound Medical, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.